Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03932773 · ClinicalTrials.gov registry record · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
A NA study of Post Traumatic Stress Disorder, sponsored by The University of Texas at Dallas.
- Recruiting
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 3
- Study locations
NCT03932773: Recruiting NA study of Post Traumatic Stress Disorder, sponsored by The University of Texas at Dallas.
NCT03932773 is a NA study of Post Traumatic Stress Disorder that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 330 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (50% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03932773, a NA study of Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by The University of Texas at Dallas.
- RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosocial functioning, and neurophysiological (i.e., electroencephalography and magnetic resonance images) measures.
Primary Outcome
Evaluation of treatment group differences on the Clinician Administered Posttraumatic Stress Disorder Scale for Diagnostic and Statistical Manual of Mental Disorders (5th edition) (CAPS-5) Total Severity Score (20 item sum, range 0-80, higher score=greater severity) in change from baseline to 6 months after the 12-week interventions. Weathers, FW, Blake, DD, Schnurr, PP, Kaloupek, DG, Marx, BP, \& Keane, TM. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). www.ptsd.va.gov: National Cen
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Processing Therapy
- DEVICE Active rTMS
- DEVICE Sham rTMS
Study Locations (3)
Texas
- Metrocare Services of Dallas - Addison
- The University of Texas at Dallas - Dallas
Florida
- Florida State University College of Medicine - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT03932773 shows while recruiting
NCT03932773 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Processing Therapy is the first listed.
NCT03932773 reports a single indexed study location in Texas, Florida.
Frequently Asked Questions
What is clinical trial NCT03932773 about?
NCT03932773 is a clinical study titled "Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD". The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosoci...
What is the current status of trial NCT03932773?
This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2019-05-01. Estimated completion is 2026-07-31.
What conditions does trial NCT03932773 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT03932773?
The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL), Active rTMS (DEVICE), Sham rTMS (DEVICE).
Who is sponsoring clinical trial NCT03932773?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03932773 being conducted?
This trial has 3 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03932773's enrollment target sits among peer trials
330 24th of 262 higher than 239 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT04900818 · 330 participants · Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI